TrialRadiation oncology (London, England)2020

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR).

Yeon Joo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.